Welcome to the WCN 2023 Interactive Program

Session Description: The aim of the session is to review Autoimmune Encephalitis in the light of the most recent descriptions of new autoantibodies, and the introduction of new immuno-oncological drugs that can contribute to causing diseases that are pathogenetically indistinguishable from classical autoimmune/paraneoplastic syndromes. Lectures will also include a practical approach to the challenges of diagnosis and management of these conditions in the clinical setting. Finally, the emerging landscape of clinical trials in Autoimmune Encephalitis will be discussed, including the challenges of studying rare neurologic diseases.Learning Objectives:1. Become updated on the landscape of Autoimmune Encephalitis, including classical paraneoplastic associations as well as those associated with newer cancer immunotherapies. 2. Learn Practical approaches to the diagnosis and management of Autoimmune Encephalitis in the clinical setting.3. Learn about ongoing international clinical trials and studies in Autoimmune Encephalitis.